6.
Kissel J, Mendell J, Rammohan K
. Microvascular deposition of complement membrane attack complex in dermatomyositis. N Engl J Med. 1986; 314(6):329-34.
DOI: 10.1056/NEJM198602063140601.
View
7.
Fasth A, Dastmalchi M, Rahbar A, Salomonsson S, Pandya J, Lindroos E
. T cell infiltrates in the muscles of patients with dermatomyositis and polymyositis are dominated by CD28null T cells. J Immunol. 2009; 183(7):4792-9.
DOI: 10.4049/jimmunol.0803688.
View
8.
Sun W, Yan S, Yang C, Yang J, Wang H, Li C
. Mesenchymal Stem Cells-derived Exosomes Ameliorate Lupus by Inducing M2 Macrophage Polarization and Regulatory T Cell Expansion in MRL/lpr Mice. Immunol Invest. 2022; 51(6):1785-1803.
DOI: 10.1080/08820139.2022.2055478.
View
9.
Lundberg I, Ulfgren A, Nyberg P, Andersson U, Klareskog L
. Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies. Arthritis Rheum. 1997; 40(5):865-74.
DOI: 10.1002/art.1780400514.
View
10.
Beatty G, Chiorean E, Fishman M, Saboury B, Teitelbaum U, Sun W
. CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans. Science. 2011; 331(6024):1612-6.
PMC: 3406187.
DOI: 10.1126/science.1198443.
View
11.
McGrath E, Doughty C, Amato A
. Autoimmune Myopathies: Updates on Evaluation and Treatment. Neurotherapeutics. 2018; 15(4):976-994.
PMC: 6277300.
DOI: 10.1007/s13311-018-00676-2.
View
12.
Kumari A, Silakari O, Singh R
. Recent advances in colony stimulating factor-1 receptor/c-FMS as an emerging target for various therapeutic implications. Biomed Pharmacother. 2018; 103:662-679.
DOI: 10.1016/j.biopha.2018.04.046.
View
13.
Davies L, Jenkins S, Allen J, Taylor P
. Tissue-resident macrophages. Nat Immunol. 2013; 14(10):986-95.
PMC: 4045180.
DOI: 10.1038/ni.2705.
View
14.
Mena H, Zubiry P, Dizier B, Mignon V, Parborell F, Schattner M
. Ceramide 1-Phosphate Protects Endothelial Colony-Forming Cells From Apoptosis and Increases Vasculogenesis In Vitro and In Vivo. Arterioscler Thromb Vasc Biol. 2019; 39(10):e219-e232.
DOI: 10.1161/ATVBAHA.119.312766.
View
15.
Civatte M, Bartoli C, Schleinitz N, Chetaille B, Pellissier J, Figarella-Branger D
. Expression of the beta chemokines CCL3, CCL4, CCL5 and their receptors in idiopathic inflammatory myopathies. Neuropathol Appl Neurobiol. 2005; 31(1):70-9.
DOI: 10.1111/j.1365-2990.2004.00591.x.
View
16.
Bartoli C, Civatte M, Pellissier J, Figarella-Branger D
. CCR2A and CCR2B, the two isoforms of the monocyte chemoattractant protein-1 receptor are up-regulated and expressed by different cell subsets in idiopathic inflammatory myopathies. Acta Neuropathol. 2001; 102(4):385-92.
DOI: 10.1007/s004010100394.
View
17.
Krausgruber T, Blazek K, Smallie T, Alzabin S, Lockstone H, Sahgal N
. IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat Immunol. 2011; 12(3):231-8.
DOI: 10.1038/ni.1990.
View
18.
Chen W, Chen Y, Liu Y, Wang X
. Autophagy in muscle regeneration: potential therapies for myopathies. J Cachexia Sarcopenia Muscle. 2022; 13(3):1673-1685.
PMC: 9178153.
DOI: 10.1002/jcsm.13000.
View
19.
Engel A, Arahata K
. Monoclonal antibody analysis of mononuclear cells in myopathies. II: Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis. Ann Neurol. 1984; 16(2):209-15.
DOI: 10.1002/ana.410160207.
View
20.
Chung T, Christopher-Stine L, Paik J, Corse A, Mammen A
. The composition of cellular infiltrates in anti-HMG-CoA reductase-associated myopathy. Muscle Nerve. 2015; 52(2):189-95.
PMC: 4510021.
DOI: 10.1002/mus.24642.
View